Skip to main content Accessibility help
×
Home

Schizophrenia with Good and Poor Outcome. I: Early Clinical Features, Response to Neuroleptics and Signs of Organic Dysfunction

  • T. Kolakowska (a1), A. O. Williams (a2), M. Ardern (a3), M. A. Reveley (a4), K. Jambor (a5), M. G. Gelder (a6) and B. M. Mandelbrote (a5)...

Summary

Seventy-seven patients with diagnosis of schizophrenia (62) or schizoaffective disorder (15) were studied 2–20 years since onset of illness, when in a stable condition. The investigation included clinical assessment, measurement of plasma concentrations of neuroleptics and prolactin, computed tomography brain scan, neuropsychological and neurological examination. Outcome of illness was classified according to the presence of chronic psychiatric symptoms and social impairment, and response to neuroleptics according to the effect of treatment in the most recent psychotic episode. Neither outcome nor response to neuroleptics was related to duration of illness. The groups with good and poor outcome differed in premorbid adjustment, age at onset and symptoms of the initial episode, but not in drug bio-availability or prolactin response. Large cerebral ventricles and cognitive impairment, but not neurological ‘soft’ signs, were associated with unfavourable outcome. The three measures of organicity were not inter-related. No clinical differences were found between chronic patients with and without signs of organic dysfunction. The findings suggest that schizophrenia with good and unfavourable outcome may be separate sub-types. However, the role of organic factors in the latter group remains unclear.

Copyright

Corresponding author

Correspondence

References

Hide All
Andreasen, N. C., Smith, M. R., Jacoby, C. G., Dennert, J. W. & Olsen, S. A. (1982) Ventricular enlargement in schizophrenia. Definition and prevalence. American Journal of Psychiatry, 139, 292296.
Bland, G. & Orn, H. (1979) Schizophrenia: Diagnostic criteria and outcome. British Journal of Psychiatry, 134, 3438.
Bleuler, M. (1972) Die schizophrenen Geistesstorungen im Lichte Pangjahriger Kranken- und Familiengeschichter. Translated 1978 as The Schizophrenic Disorders: Long-Term Patient and Family Studies by Clements, S. M. London & New Haven: Yale University Press.
Brockington, I. F., Kendell, R. E., Kellett, J. M., Curry, S. H. & Wainwright, S. (1978) Trials of lithium, chlorpromazine and amitriptyline in schizo-affective patients. British Journal of Psychiatry, 133, 162168.
Carpenter, W. T., Bariko, J. J., Strauss, M. D. & Hawk, A. B. (1978) Signs and symptoms as predictors of outcome: A report from the international pilot study of schizophrenia. American Journal of Psychiatry, 135, 940945.
Ciompi, L. C. (1980) The natural history of schizophrenia. British Journal of Psychiatry, 136, 413420.
Golden, C. J., Moses, J. A., Zelazowski, R., Graber, B., Zatz, L. M., Horvath, T. B. & Berner, P. A. (1980) Cerebral ventricular size and neuropsychological impairment in young chronic schizophrenics: Measurements by the standardised Luria-Nebraska Neuropsychological Battery. Archives of General Psychiatry, 37, 619623.
Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology. Rockville, Maryland: National Institute for Mental Health.
Hawk, A.B., Carpenter, W. T. & Strauss, J. S. (1975) Diagnostic criteria and five-year outcome in schizophrenia. Archives of General Psychiatry, 32, 343347.
Higgins, J. (1969) Process–Reactive schizophrenia. Journal of Nervous and Mental Disease, 149, 450472.
Huber, G., Gross, G. & Schutter, R. (1975) A long-term follow-up study of schizophrenia: Clinical course and prognosis. Acta Psychiatrica Scandinavica, 52, 4957.
Jackson, H. J. (1931) Selected Writings. London: Hodder & Stoughton.
Johnstone, E. C., Crow, T. J., Frith, C. D., Stevens, K. & Husband, J. (1976) Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet, i, 924926.
Johnstone, E. C., Crow, T. J., & Husband, J., Frith, C. D., Gold, A. & Stevens, K. (1979) The outcome of severe acute schizophrenic illness after one year. British Journal of Psychiatry, 134, 2833.
Kendell, R. E., Brockington, I. F. & Leff, J. P. (1979) Prognostic implications of six alternative definitions of schizophrenia. Archives of General Psychiatry, 36, 2531.
Kolakowska, T. & Gelder, M. (1980) A model to separate drug-related and illness-related outcomes of neuroleptic treatment. In Phenothiazines and Structurally Related Drugs, ed. Usdin, E., Eckert, H. & Forrest, I. Amsterdam: Elsevier.
Kolakowska, T. & Gelder, M., Orr, M. W., Gelder, M. G., Heggie, M., Wiles, D. H. & Franklin, M. (1979) Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: A replication. British Journal of Psychiatry, 135, 352359.
Kolakowska, T. & Gelder, M., Heggie, M., Wiles, D. H. & Franklin, M., Gelder, M. G. & Orr, M. W. (1980) Drug-related and illness-related factors in the outcome of chlorpromazine treatment: Testing a model. Psychological Medicine, 10, 335343.
Kolakowska, T. & Gelder, M., Heggie, M., Wiles, D. H. & Franklin, M., Gelder, M. G. & Orr, M. W., Williams, A. O., Jambor, K. & Arden, M. (1985) Schizophrenia with good and poor outcome. III: Neurological ‘soft’ signs, cognitive impairment and their clinical significance. British Journal of Psychiatry, 146, in press.
Langfeldt, G. (1937) The prognosis in schizophrenia and the factors influencing the course of the disease. Acta Psychiatrica Scandinavica, Suppl.13, 1228.
Mackay, A. V. P. & Crow, T. J. (1980) Positive and negative schizophrenic symptoms and the role of dopamine. British Journal of Psychiatry, 137, 379386.
Malec, J. (1978) Neuropsychological assessment of schizophrenia versus brain damage: A review. Journal of Nervous and Mental Disease, 166, 507516.
National Institute of Mental Health (1964) Phenothiazine treatment in schizophrenia. Archives of General Psychiatry, 10, 246261.
Nelson, H. E. & O'Connell, A. D. (1978) Dementia: The estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex, 14, 234244.
Overall, J. E. & Gorham, D. R. (1962) The brief psychiatric rating scale. Psychological Reports, 10, 799812.
Procci, W. R. (1976) Schizo-affective psychosis: Fact or fiction? Archives of General Psychiatry, 33, 11671178.
Ouitkin, F., Rifkin, A. & Klein, D. F. (1976) Neurologic soft signs in schizophrenia and character disorders. Archives of General Psychiatry, 33, 845853.
Ries, R. K., Wilson, L., Bokan, J. A. & Chiles, J. A. (1981) ECT in medication-resistant schizoaffective disorder. Comprehensive Psychiatry, 22, 167173.
Rochford, J. M., Detre, T., Tucker, G. J. & Harrow, M. (1970) Neuropsychological impairments in functional psychiatric diseases. Archives of General Psychiatry, 22, 114119.
Simpson, G. H. & Angus, J. W. S. (1970) A rating scale for extrapyramidal side-effects. Acta Psychiatrica Scandinavica, Suppl. 212, 1119.
Smith, R. C., Crayton, J. W., Tamminga, C., Dekrmenjian, H. & Schoolar, J. C. (1979) Blood levels of neuroleptic drugs, clinical response, and plasma prolactin in chronic non-responding schizophrenic patients. In The Kinetics of Psychiatric Drugs, ed. Schoolar, J. C. & Claghom, J. L. New York: Brunner/Mazel.
Spitzer, R. L., Endicott, J. J. & Robins, E. (1975) Research Diagnostic Criteria. New York: New York State Psychiatric Institute.
Stephens, J. H. (1978) Long-term prognosis and follow-up in schizophrenia. Schizophrenia Bulletin, 4, 2547.
Weinberger, D. R., Wagner, R. L. & Wyatt, R. J. (1983) Neuropathological studies of schizophrenia: A selective review. Schizophrenia Bulletin, 9, 193212.
Wiles, D. H. & Franklin, M. (1978) Radioimmunoassay for fluphenazinc in human plasma. British Journal of Clinical Pharmacology, 5, 265268.
Williams, A. O., Reveley, M. A., Kolakowska, T., Ardern, M. & Mandelbrote, B. M. (1985) Schizophrenia with good and poor outcome. II Cerebral ventricular size and clinical significance. British Journal of Psychiatry, 146, 237244.
Wing, J. K. (1966) Five-year outcome in early schizophrenia. Proceedings of the Royal Society, 59, 1723.
Wing, J. K., Cooper, J. E. & Sartorius, N. (1974) The Measurement and Classification of Psychiatric Symptoms. Cambridge: Cambridge University Press.

Schizophrenia with Good and Poor Outcome. I: Early Clinical Features, Response to Neuroleptics and Signs of Organic Dysfunction

  • T. Kolakowska (a1), A. O. Williams (a2), M. Ardern (a3), M. A. Reveley (a4), K. Jambor (a5), M. G. Gelder (a6) and B. M. Mandelbrote (a5)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Schizophrenia with Good and Poor Outcome. I: Early Clinical Features, Response to Neuroleptics and Signs of Organic Dysfunction

  • T. Kolakowska (a1), A. O. Williams (a2), M. Ardern (a3), M. A. Reveley (a4), K. Jambor (a5), M. G. Gelder (a6) and B. M. Mandelbrote (a5)...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *